(Q46309026)

21 December 2017

title

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study (English)

1 reference

21 December 2017

15

Peter Hau

0 references

Heinz Reichmann

8

object named as

Heinz Reichmann

1 reference

21 December 2017

6

Michael Linnebank

1 reference

21 December 2017

author name string

Hendrik Pels

1

1 reference

21 December 2017

Annika Juergens

2

1 reference

21 December 2017

Axel Glasmacher

3

1 reference

21 December 2017

Holger Schulz

4

1 reference

21 December 2017

Andreas Engert

5

1 reference

21 December 2017

Gabriele Schackert

7

1 reference

21 December 2017

Frank Kroschinsky

9

1 reference

21 December 2017

Marlies Vogt-Schaden

10

1 reference

21 December 2017

Gerlinde Egerer

11

1 reference

21 December 2017

Udo Bode

12

1 reference

21 December 2017

Carlo Schaller

13

1 reference

21 December 2017

Monika Lamprecht

14

1 reference

21 December 2017

Peter Hau

15

1 reference

21 December 2017

Martina Deckert

16

1 reference

21 December 2017

Rolf Fimmers

17

1 reference

21 December 2017

Christopher Bangard

18

1 reference

21 December 2017

Ingo G H Schmidt-Wolf

19

1 reference

21 December 2017

Uwe Schlegel

20

1 reference

21 December 2017

publication date

18 October 2008

1 reference

21 December 2017

Journal of Neuro-Oncology

published in

1 reference

21 December 2017

volume

91

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

299-305

1 reference

21 December 2017

A multicenter study of treatment of primary CNS lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9712-4

Cognitive status and quality of life after treatment for primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9712-4

Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9712-4

Cognitive functions in survivors of primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9712-4

Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9712-4

Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.

21 January 2018

1 reference

12 December 2020

Neuro-oncology update: 2005.

1 reference

12 December 2020

Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma

1 reference

12 December 2020

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

1 reference

12 December 2020

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma

1 reference

12 December 2020

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

1 reference

12 December 2020

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

1 reference

12 December 2020

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients

1 reference

12 December 2020

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

1 reference

12 December 2020

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

12 December 2020

Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms

1 reference

12 December 2020

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

12 December 2020

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

1 reference

12 December 2020

1 reference

12 December 2020

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

1 reference

12 December 2020

Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments

1 reference

12 December 2020

Treatment for primary CNS lymphoma: the next step

1 reference

12 December 2020

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

1 reference

12 December 2020

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

1 reference

12 December 2020

10.1007/S11060-008-9712-4

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017